Enhanced Schizophrenia Treatment with Approved Drug Combination

This study focuses on improving the treatment of Schizophrenia. It aims to help patients who are currently using one of the following medications: Abilify, Risperdal, Seroquel, or Zyprexa. The goal is to find a better way to manage symptoms and enhance the quality of life for these individuals. This research is important because it could lead to more effective care for people living with Schizophrenia. The study involves testing a combination of two drugs that are already approved for use. Participants will continue taking their current medication and add the new drug to their treatment plan. The effects of this combination will be closely monitored. The study will measure how well the new combination works in managing symptoms and improving daily functioning. As with any study, there may be potential risks and benefits, which will be fully explained to participants before they decide to take part.